Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 422

1.

Nuclear Medicine Training: Two Different Pathways?

Biersack HJ.

J Nucl Med. 2018 Aug;59(8):1335. doi: 10.2967/jnumed.118.210401. Epub 2018 Mar 15. No abstract available.

PMID:
29545377
2.

Diagnostic accuracy of [99mTc]Tc-Sestamibi in the assessment of thyroid nodules.

Yordanova A, Mahjoob S, Lingohr P, Kalff J, Türler A, Palmedo H, Biersack HJ, Kristiansen G, Farahati J, Essler M, Ahmadzadehfar H.

Oncotarget. 2017 Oct 17;8(55):94681-94691. doi: 10.18632/oncotarget.21866. eCollection 2017 Nov 7.

3.

Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis.

Sabet A, Haug AR, Eiden C, Auernhammer CJ, Simon B, Bartenstein P, Biersack HJ, Ezziddin S.

Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):74-83. eCollection 2017.

4.

Radionuclide therapy of malignant bone lesions.

Fischer M, Biersack HJ.

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):728-729. doi: 10.1007/s00259-016-3574-3. Epub 2016 Dec 9. No abstract available.

PMID:
27942833
5.

Radiosynoviorthesis in hemophilic arthropathy: pathologic blood pool imaging on pre-therapeutic bone scintigraphy is not a predictor of treatment success.

Sabet A, Strauss AC, Schmolders J, Bornemann R, Sabet A, Oldenburg J, Pennekamp PH, Biersack HJ, Ezziddin S.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):461-467. doi: 10.1007/s00259-016-3549-4. Epub 2016 Oct 28.

PMID:
27796541
6.

Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.

Sabet A, Binse I, Dogan S, Koch A, Rosenbaum-Krumme SJ, Biersack HJ, Biermann K, Ezziddin S.

Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):190-195. doi: 10.1007/s00259-016-3485-3. Epub 2016 Aug 16.

PMID:
27530124
7.

Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: A multi-institutional registry study with prospective follow-up.

Hörsch D, Ezziddin S, Haug A, Gratz KF, Dunkelmann S, Miederer M, Schreckenberger M, Krause BJ, Bengel FM, Bartenstein P, Biersack HJ, Pöpperl G, Baum RP.

Eur J Cancer. 2016 May;58:41-51. doi: 10.1016/j.ejca.2016.01.009. Epub 2016 Mar 2.

PMID:
26943056
8.

Advances in Peptide Receptor Radionuclide Therapy.

Sabet A, Biersack HJ, Ezziddin S.

Semin Nucl Med. 2016 Jan;46(1):40-6. doi: 10.1053/j.semnuclmed.2015.09.005. Review.

PMID:
26687856
9.

Discovery of rhenium and masurium (technetium) by Ida Noddack-Tacke and Walter Noddack. Forgotten heroes of nuclear medicine.

Biersack HJ, Stelzner F, Knapp FF.

Nuklearmedizin. 2015;54(6):N50-4. doi: 10.3413/nuk2015050001. Epub 2015 Oct 19.

PMID:
26478117
10.

[The role of PET in lung cancer staging].

Gärtner FC, Buermann J, Skowasch D, Biersack HJ, Essler M.

Dtsch Med Wochenschr. 2015 Apr;140(9):679-83. doi: 10.1055/s-0041-101521. Epub 2015 Apr 29. German.

PMID:
25924049
11.

Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy. A new tool to differentiate psoriatic from rheumatoid arthritis.

Ezziddin S, Khalaf F, Seidel M, Al Zreiqat A, Wilsmann-Theis D, Simon B, Biersack HJ, Sabet A.

Nuklearmedizin. 2015;54(4):183-9. doi: 10.3413/Nukmed-0698-14-09. Epub 2015 Apr 13.

PMID:
25864944
12.

Specific efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in advanced neuroendocrine tumours of the small intestine.

Sabet A, Dautzenberg K, Haslerud T, Aouf A, Sabet A, Simon B, Mayer K, Biersack HJ, Ezziddin S.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1238-46. doi: 10.1007/s00259-015-3041-6. Epub 2015 Mar 26.

PMID:
25808630
13.

[SPECT/CT: Benefit and indications of hybrid imaging].

Ahmadzadehfar H, Muckle M, Essler M, Biersack HJ, von Mallek D.

Dtsch Med Wochenschr. 2015 Mar;140(6):434-8. doi: 10.1055/s-0041-101022. Epub 2015 Mar 16. Review. German. No abstract available.

PMID:
25774736
14.

Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer.

Sabet A, Meyer C, Aouf A, Sabet A, Ghamari S, Pieper CC, Mayer K, Biersack HJ, Ezziddin S.

Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):370-6. doi: 10.1007/s00259-014-2935-z. Epub 2014 Oct 29.

PMID:
25351506
15.

Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system.

Ezziddin S, Adler L, Sabet A, Pöppel TD, Grabellus F, Yüce A, Fischer HP, Simon B, Höller T, Biersack HJ, Nagarajah J.

J Nucl Med. 2014 Aug;55(8):1260-6. doi: 10.2967/jnumed.114.137166. Epub 2014 May 29.

16.

Significance of multiple nodal basin drainage in patients with truncal melanoma.

Ahmadzadehfar H, Hinz T, Wierzbicki A, Höller T, Habibi E, Wenzel J, Muckle M, Biersack HJ, Essler M, Schmid-Wendtner M.

Q J Nucl Med Mol Imaging. 2016 Sep;60(3):274-9. Epub 2014 May 21.

PMID:
24844255
17.

Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement.

Sabet A, Khalaf F, Yong-Hing CJ, Sabet A, Haslerud T, Ahmadzadehfar H, Guhlke S, Grünwald F, Biersack HJ, Ezziddin S.

Nuklearmedizin. 2014;53(2):54-9. doi: 10.3413/Nukmed-0614-13-08.

PMID:
24777355
18.

Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.

Sabet A, Ahmadzadehfar H, Bruhman J, Sabet A, Meyer C, Wasmuth JC, Pieper CC, Biersack HJ, Ezziddin S.

Nuklearmedizin. 2014;53(2):39-45. doi: 10.3413/Nukmed-0622-13-09.

PMID:
24777354
19.

Appearance of extraosseous pelvic Ewing sarcoma on triphasic bone scan.

Muckle M, Habibi E, Simon B, Zipfel M, Biersack HJ, Ahmadzadehfar H.

Clin Nucl Med. 2014 Apr;39(4):406-8. doi: 10.1097/RLU.0000000000000381.

PMID:
24566405
20.

Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours.

Ezziddin S, Khalaf F, Vanezi M, Haslerud T, Mayer K, Al Zreiqat A, Willinek W, Biersack HJ, Sabet A.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):925-33. doi: 10.1007/s00259-013-2677-3. Epub 2014 Feb 7.

PMID:
24504504

Supplemental Content

Loading ...
Support Center